Company intelligence / Profile preview

Only Orphans Cote

Cambridge, Massachusetts, United Statescoteorphan.com ↗

Ownership: Private
Development stage: Other

Overview

Only Orphans Cote is a leading regulatory affairs advisory firm specializing in orphan drug designation and rare disease drug development. The team leverages deep expertise—including that of Dr. Timothy Coté, former Director of the FDA Office of Orphan Products Development—to help clients secure FDA/EMA orphan designations and navigate complex regulatory pathways for marketing authorization.

Therapeutic areas: Rare Diseases
Industry: Consulting

Beyond the preview

Go deeper on Only Orphans Cote.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Only Orphans Cote.

Explore the full profile